The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gastro Esophageal Reflux Disease (GERD) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease (GERD) Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gastro Esophageal Reflux Disease (GERD) Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gastro Esophageal Reflux Disease (GERD) Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Novartis AG
GlaxoSmithKline
Merck
Medtronic
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids

Segment by Application
Hospital
Clinic
Medical Center
Others